Ann Dermatol.  2018 Jun;30(3):290-295. 10.5021/ad.2018.30.3.290.

The Evaluation of Contact Sensitivity with Standard and Cosmetic Patch Test Series in Rosacea Patients

• Erdogan HK
• Bulur I
• Saracoglu
• Bilgin M

• KMID: 2419169
• DOI: http://doi.org/10.5021/ad.2018.30.3.290

Abstract

BACKGROUND
Rosacea is a common dermatosis characterized by erythema, telangiectasia, papules and pustules.
OBJECTIVE
We aimed to evaluate contact sensitivity in the rosacea patients.
METHODS
We included 65 rosacea patients and 60 healthy volunteers in the study. The patient and control groups were patch tested with European baseline series and cosmetic series.
RESULTS
A positive reaction to at least 1 allergen in the European standard series was found in 32.3% of rosacea patients and 20.0% of subjects in the control group while the relevant numbers were 30.8% of rosacea patients and 10% of controls with the cosmetic series (p=0.08). In total, we found a positive reaction to at least 1 allergen in 38.5% of patients and 25.0% of controls (p=0.15). We did not find a statistically significant relationship between a positive reaction to 1 allergen in total and the gender, skin type, rosacea type, ocular involvement, age and disease duration. There were more symptoms in patients with a positive reaction to allergens (p < 0.001).
CONCLUSION
Contact sensitivity was detected more common in rosacea patients. Patch testing may be useful in the treatment and follow up of rosacea patients especially if symptoms such as itching, burning and stinging are present.

Keyword

Contact sensitivity; Patch tests; Rosacea

MeSH Terms

Allergens
Bites and Stings
Burns
Dermatitis, Contact*
Erythema
Follow-Up Studies
Healthy Volunteers
Humans
Patch Tests*
Pruritus
Rosacea*
Skin
Skin Diseases
Telangiectasis
Allergens

Reference

1. Tüzün Y, Wolf R, Kutlubay Z, Karakuş O, Engin B. Rosacea and rhinophyma. Clin Dermatol. 2014; 32:35–46. PMID: 24314376.

2. Steinhoff M, Schauber J, Leyden JJ. New insights into rosacea pathophysiology: a review of recent findings. J Am Acad Dermatol. 2013; 69(6 Suppl 1):S15–S26. PMID: 24229632.

3. Dorschner RA, Williams MR, Gallo RL. Rosacea, the face of innate immunity. Br J Dermatol. 2014; 171:1282–1284. PMID: 25523247.

4. Meyer-Hoffert U, Schröder JM. Epidermal proteases in the pathogenesis of rosacea. J Investig Dermatol Symp Proc. 2011; 15:16–23.

5. Wolf R, Orion E, Matz H. Co-existing sensitivity to metronidazole and isothiazolinone. Clin Exp Dermatol. 2003; 28:506–507. PMID: 12950340.

6. Swanson LA, Warshaw EM. Allergic contact dermatitis to topical brimonidine tartrate gel 0.33% for treatment of rosacea. J Am Acad Dermatol. 2014; 71:832–833. PMID: 25219708.

7. Madsen JT, Thormann J, Kerre S, Andersen KE, Goossens A. Allergic contact dermatitis to topical metronidazole-3 cases. Contact Dermatitis. 2007; 56:364–366. PMID: 17577385.

8. Cookson H, McFadden J, White J, White IR. Allergic contact dermatitis caused by Mirvaso®, brimonidine tartrate gel 0.33%, a new topical treatment for rosaceal erythema. Contact Dermatitis. 2015; 73:366–367. PMID: 26768997.

9. Darlenski R, Kazandjieva J, Tsankov N, Fluhr JW. Acute irritant threshold correlates with barrier function, skin hydration and contact hypersensitivity in atopic dermatitis and rosacea. Exp Dermatol. 2013; 22:752–753. PMID: 24112695.

10. Corazza M, la Malfa W, Lombardi A, Maranini C, Virgili A. Role of allergic contact dermatitis in rosacea. Contact Dermatitis. 1997; 37:40–41. PMID: 9255491.

11. Jappe U, Schnuch A, Uter W. Rosacea and contact allergy to cosmetics and topical medicaments--retrospective analysis of multicentre surveillance data 1995-2002. Contact Dermatitis. 2005; 52:96–101. PMID: 15725288.

12. Jappe U, Schäfer T, Schnuch A, Uter W. Contact allergy in patients with rosacea: a clinic-based, prospective epidemiological study. J Eur Acad Dermatol Venereol. 2008; 22:1208–1214. PMID: 18452530.

13. Pónyai G, Kiss D, Németh I, Temesvári E. Contact hypersensitivity in rosacea--a study in 82 patients. J Eur Acad Dermatol Venereol. 2012; 26:1171–1172. PMID: 21929553.

14. Çakmak SK, Gönül MT, Kılıç A, Gül Ü. The role of contact allergy in rosacea. J Turk Acad Dermatol. 2007; 1:71201a.

15. Moustafa F, Lewallen RS, Feldman SR. The psychological impact of rosacea and the influence of current management options. J Am Acad Dermatol. 2014; 71:973–980. PMID: 24993600.

16. Forton FM. Papulopustular rosacea, skin immunity and Demodex: pityriasis folliculorum as a missing link. J Eur Acad Dermatol Venereol. 2012; 26:19–28.

17. Pelle MT, Crawford GH, James WD. Rosacea: II. Therapy. J Am Acad Dermatol. 2004; 51:499–512. PMID: 15389184.